在Ph1+急性淋巴细胞白血病中,波纳替尼的脑脊液分布和药理动力学
Pierre Walczak1, Sofiane Fodil1,2, Nicolas Vignal3
1Hematology Department, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Blood
|June 25, 2024
概括
氨酸激酶抑制剂对中枢神经系统 (CNS) 疾病的疗效尚不清楚. 波纳替尼在费城阳性急性淋巴细胞白血病患者中显示出低于最佳的中枢神经系统暴露,因为脑脊液度低于有效值.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 氨酸激酶抑制剂 (TKI) 在治疗中枢神经系统 (CNS) 疾病中的疗效尚未得到充分证实.
- 在治疗某些血液性恶性瘤方面,TKIs至关重要,但它们透到中枢神经系统是一个重大挑战.
研究的目的:
- 评估费城阳性急性淋巴细胞白血病 (Ph+ ALL) 患者中波纳提尼布的中枢神经系统 (CNS) 分布情况.
- 为了确定ponatinib是否在中枢神经系统内达到治疗度以有效治疗中枢神经系统白血病.
主要方法:
- 在16名被诊断为费城阳性急性淋巴细胞白血病 (Ph+ ALL) 的患者中进行了一项药理动力学研究.
- 脑脊液 (CSF) 样本被采集来测量波纳替尼的度.
- 将CSF度与最佳中枢神经系统暴露的预定义值 (40nM) 相比较.
主要成果:
- 在16名患有Ph+ALL的患者中,测量了脑脊髓液 (CSF) 中ponatinib的度.
- 观察到的脊髓液中ponatinib度始终低于40nM的值.
- 这表明中枢神经系统中药物水平不足以有效控制疾病.
结论:
- 在中枢神经系统 (CNS) 中的波纳替尼暴露似乎不足以治疗费城阳性急性淋巴细胞白血病 (Ph+ ALL).
- 这些发现表明,标准剂量可能无法在中枢神经系统中达到治疗度,这可能会限制其在中枢神经系统白血病中的疗效.
- 对Ph+ ALL中中枢神经系统参与的最佳剂量或替代策略进行进一步的研究是有必要的.
相关概念视频
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Factors Affecting Drug Distribution: Physiological Barriers
196
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
196
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
156
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
156
Factors Affecting Drug Distribution: Tissue Permeability
184
The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
184
Drug Distribution: Plasma Protein Binding
5.5K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.5K
Nonlinear Pharmacokinetics: Role of Transporters
47
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
47


